Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis

Modi AA, Nazario H, Trotter JF, et al. Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis. Liver Transpl. 2016;22(3):281-286.

Publication Type:

Journal Article

Authors:

Modi, AA.; Nazario, H.; Trotter, JF; et, al

Source:

Liver Transpl, Volume 22, Issue 3, p.281-286 (2016)

Cited On:

Patients With Decompensated Cirrhosis

Export Citation:

RIS Format

Top